Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by 2skytracker2on Feb 26, 2013 11:44pm
150 Views
Post# 21046760

RE: RE: Opportunity!!!

RE: RE: Opportunity!!!

Without showing a bunch of numbers. If this sold tomorrow we would probably see (minimum) 62 cents per share. We are pumping 400 barrels per day, using a sale price of $70 per bl = $10,000,000 per year this does not include any reserves or assets of any kind (which we have), There are people on this site that are far more knowledgable and capable of giving you proper numbers and insight than I, They all seem to have gotten complacent ( no malice intended) and no longer see the potential here. There are only 60ml shares outstanding, most of which are owned by institutions, the company has really good management team doing a great job of running a company, (thats there job) but not very good at promoting stock.Lets think about this 60ml SHARES X .07 =  $4,200,000 Does this seem right to you. THERE IS BIG POTENTIAL HERE PEOPLE. with only 60ml shares OS and most of them owned by institutions, this SP. could and will make a big move sometime in the not to distant future..IMO SKY2

 

 

 

Bullboard Posts